87 related articles for article (PubMed ID: 1666669)
1. [Ki-67 antigen, a cell cycle and tumor growth marker].
Seigneurin D; Guillaud P
Pathol Biol (Paris); 1991 Dec; 39(10):1020-8. PubMed ID: 1666669
[TBL] [Abstract][Full Text] [Related]
2. Quantification and topographical description of Ki-67 antibody labelling during the cell cycle of normal fibroblastic (MRC-5) and mammary tumour cell lines (MCF-7).
Guillaud P; du Manoir S; Seigneurin D
Anal Cell Pathol; 1989 Feb; 1(1):25-39. PubMed ID: 2488698
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
[TBL] [Abstract][Full Text] [Related]
4. Ki-67 labeling in postmitotic cells defines different Ki-67 pathways within the 2c compartment.
du Manoir S; Guillaud P; Camus E; Seigneurin D; Brugal G
Cytometry; 1991; 12(5):455-63. PubMed ID: 1935459
[TBL] [Abstract][Full Text] [Related]
5. Effect of staurosporine on MOLT-4 cell progression through G2 and on cytokinesis.
Traganos F; Gong J; Ardelt B; Darzynkiewicz Z
J Cell Physiol; 1994 Mar; 158(3):535-44. PubMed ID: 8126077
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle progression and phenotypic modification of Ki67 antigen-negative G1- and G2-phase cells in phorbol ester-treated Molt-4 human leukemia cells.
Tsurusawa M; Fujimoto T
Cytometry; 1995 Jun; 20(2):146-53. PubMed ID: 7664625
[TBL] [Abstract][Full Text] [Related]
7. Three parameter flow cytometric analysis for simultaneous detection of cytokeratin, proliferation associated antigens and DNA content.
Schutte B; Tinnemans MM; Pijpers GF; Lenders MH; Ramaekers FC
Cytometry; 1995 Oct; 21(2):177-86. PubMed ID: 8582238
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between the Ki-67 nuclear antigen content and cell-cycle perturbation on WiDr cells treated with 5-FU].
Tagawa Y; Kawazoe N; Sawai T; Yamaguchi S; Tomita M
Hum Cell; 1993 Jun; 6(2):121-5. PubMed ID: 8217950
[TBL] [Abstract][Full Text] [Related]
9. Analysis of cell cycle-related Ki-67 and p120 expression by flow cytometric BrdUrd-Hoechst/7AAD and immunolabeling technique.
Endl E; Steinbach P; Knüchel R; Hofstädter F
Cytometry; 1997 Nov; 29(3):233-41. PubMed ID: 9389440
[TBL] [Abstract][Full Text] [Related]
10. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.
Steck K; el-Naggar AK
Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161
[TBL] [Abstract][Full Text] [Related]
11. A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer.
Scott IS; Morris LS; Bird K; Davies RJ; Vowler SL; Rushbrook SM; Marshall AE; Laskey RA; Miller R; Arends MJ; Coleman N
J Pathol; 2003 Oct; 201(2):187-97. PubMed ID: 14517835
[TBL] [Abstract][Full Text] [Related]
12. The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigen.
Rudolph P; Knüchel R; Endl E; Heidebrecht HJ; Hofstäder F; Parwaresch R
Mod Pathol; 1998 May; 11(5):450-6. PubMed ID: 9619598
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies.
Gerdes J
Semin Cancer Biol; 1990 Jun; 1(3):199-206. PubMed ID: 2103495
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 labeling indices in non-small cell lung cancer: comparison between image cytometry and flow cytometry.
Ishikuro A; Dosaka-Akita H; Kato M; Fujino M; Isobe H; Miyamoto H; Inoue K; Kawakami Y
Cytometry; 1997 Aug; 30(4):186-91. PubMed ID: 9298837
[TBL] [Abstract][Full Text] [Related]
16. The Ki-67 protein: from the known and the unknown.
Scholzen T; Gerdes J
J Cell Physiol; 2000 Mar; 182(3):311-22. PubMed ID: 10653597
[TBL] [Abstract][Full Text] [Related]
17. Relationship of the epidermal growth factor-receptor to the growth fraction (Ki-67 antibody) and the flow cytometric S-phase as cell kinetics parameters, in human mammary carcinomas.
Gasparini G; Reitano M; Bevilacqua P; Meli S; Pozza F; Santini G
Anticancer Res; 1991; 11(4):1597-603. PubMed ID: 1746917
[TBL] [Abstract][Full Text] [Related]
18. [Histochemical and histomorphometric studies on growth fractions in human breast carcinoma].
Hahn J; Linhart W; Müller H; Renz S; Schneider M
Verh Dtsch Ges Pathol; 1990; 74():262-7. PubMed ID: 1708598
[TBL] [Abstract][Full Text] [Related]
19. Posttranslational modifications of the KI-67 protein coincide with two major checkpoints during mitosis.
Endl E; Gerdes J
J Cell Physiol; 2000 Mar; 182(3):371-80. PubMed ID: 10653604
[TBL] [Abstract][Full Text] [Related]
20. Effects of benzo[a]pyrene on concanavalin A-stimulated human peripheral blood mononuclear cells in vitro: inhibition of proliferation but no effect on parameters related to the G1 phase of the cell cycle.
Mudzinski SP
Toxicol Appl Pharmacol; 1993 Apr; 119(2):166-74. PubMed ID: 8097600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
